The shelf effectiveness opens a near-term dilution window. Monitor for any takedown announcements or ATM usage. The company's going concern risk and $30M cash burn rate suggest additional capital raises are likely within 6-12 months. The resale shares create overhang but are already registered — watch for insider selling or secondary offerings.
Price Chart
Executive Summary
Cue Biopharma's S-3 shelf registration (File No. 333-296456) became effective on June 17, 2026, enabling the company to sell securities. The shelf was filed 15 days ago and covers 4,090,908 shares for resale by selling stockholders, including shares from pre-funded warrants and warrants issued in a $30M private placement. The company receives no proceeds from the resale except potential cash exercises at $11.00 per share. This effectiveness adds near-term dilution overhang given the company's going concern risk and need for additional capital.
Key Facts
- S-3 shelf registration (File No. 333-296456) became effective on June 17, 2026
- Shelf covers 4,090,908 shares for resale by selling stockholders from prior private placement
- Company received $30M gross proceeds from private placement; no proceeds from resale except warrant exercises at $11.00/share
- Company faces going concern risk and needs additional capital per prospectus
- Market cap ~$112M; stock trades on Nasdaq
Financial Impact
Up to $45M potential dilution from 4.09M shares at current ~$11/share (warrant exercise price), but resale shares are already issued/outstanding; no new cash to company
Risk Factors
- Dilution from shelf takedown or resale of registered shares
- Going concern risk — company may need additional capital within 12 months
- Potential stock price pressure from selling stockholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002046 |
| Document: 9999999995-26-002046-index.html | 9999999995-26-002046 |
| Document: 9999999995-26-002046.txt | 9999999995-26-002046 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | Insider Cluster | $18.67 $16.71 | ▲ +10.50% | ▲ +9.39% | $18.07 (+3.21%) |
Oct 13, 2026 13d ago | 144 | $18.60 $18.67 | ▲ +0.38% | ▲ +0.09% | $18.07 (−2.85%) |
Oct 8, 2026 19d ago | SC 13G/A | $22.33 $27.66 | ▲ +23.87% | ▲ +23.27% | $18.07 (−19.08%) |
Sep 21, 2026 5w ago | 8-K | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.07 (−36.08%) |
Sep 20, 2026 5w ago | Press Release | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.07 (−36.08%) |
Aug 21, 2026 9w ago | EFFECT | $23.98 $23.18 | ▲ +3.34% | ▲ +3.04% | $18.07 (+24.65%) |
Aug 17, 2026 10w ago | Insider Cluster | $25.70 $26.28 | ▼ −2.26% | ▼ −2.05% | $18.07 (+29.69%) |
Aug 14, 2026 10w ago | Press Release | $27.64 $25.70 | ▼ −7.02% | ▼ −6.34% | $18.07 (−34.62%) |
Aug 13, 2026 10w ago | 144 | $34.20 $27.64 | ▼ −19.18% | ▼ −18.71% | $18.07 (−47.16%) |
Jul 9, 2026 15w ago | Press Release | $36.78 $30.92 | ▼ −15.93% | ▼ −15.17% | $18.07 (−50.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers